Lafutidine has been investigated in Peptic Ulcer, Community-acquired Pneumonia, and Gastroesophageal Reflux Disease (GERD). Its therapeutic use is listed as gastrointestinal agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include loctidine and Protecadin. Its PubChem CID is 5282136.
Lafutidine
| CAS No | 118288-08-7 |
|---|---|
| Molecular Formula | C22H29N3O4S |
| Molecular Weight | 431.60 g/mol |
| Synonyms | 2-(furan-2-ylmethylsulfinyl)-N-[(Z)-4-[[4-(piperidin-1-ylmethyl)-2-pyridinyl]oxy]but-2-enyl]acetamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Lafutidine has been investigated in Peptic Ulcer, Community-acquired Pneumonia, and Gastroesophageal Reflux Disease (GERD). Its therapeutic use is listed as gastrointestinal agents.
The listed CAS number is 118288-08-7.
The listed molecular formula is C22H29N3O4S.
The listed molecular weight is 431.60 g/mol.
2-(furan-2-ylmethylsulfinyl)-N-[(Z)-4-[[4-(piperidin-1-ylmethyl)-2-pyridinyl]oxy]but-2-enyl]acetamide.
The source lists loctidine and Protecadin.